Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128)
Jeremie Guedj, Harel Dahari, Emi Shudo, Patrick Smith, Alan S. Perelson – 16 November 2011 – Mericitabine (RG7128) is a nucleoside polymerase inhibitor (NPI), which requires intracellular uptake and phosphorylation to two active triphosphates. Mathematical modeling has provided important insights for characterizing hepatitis C virus (HCV) RNA decline and estimating in vivo effectiveness of antiviral agents; however, it has not been used to characterize viral kinetics with NPIs.